286 related articles for article (PubMed ID: 26779739)
1. Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015.
Lahra MM; Enriquez RP;
Commun Dis Intell Q Rep; 2015 Dec; 39(4):E628-30. PubMed ID: 26779739
[No Abstract] [Full Text] [Related]
2. Australian gonococcal surveillance programme, 1 April to 30 June 2014.
Lahra MM;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E390-2. PubMed ID: 25631604
[No Abstract] [Full Text] [Related]
3. Australian Gonococcal Surveillance Programme, 1 July to 30 September 2015.
Lahra MM; Enriquez RP;
Commun Dis Intell Q Rep; 2016 Mar; 40(1):E179-81. PubMed ID: 27080026
[No Abstract] [Full Text] [Related]
4. Australian Gonococcal Surveillance Programme annual report, 2013.
Lahra MM;
Commun Dis Intell Q Rep; 2015 Mar; 39(1):E137-45. PubMed ID: 26063087
[TBL] [Abstract][Full Text] [Related]
5. Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016
.
Lahra MM; Enriquez RP;
Commun Dis Intell Q Rep; 2017 Mar; 41(1):E109-E110. PubMed ID: 28385144
[No Abstract] [Full Text] [Related]
6. Australian Gonococcal Surveillance Programme Annual Report, 2022.
Lahra MM; Van Hal S; Hogan TR
Commun Dis Intell (2018); 2023 Aug; 47():. PubMed ID: 37817315
[TBL] [Abstract][Full Text] [Related]
7. Australian Gonococcal Surveillance Programme, 1 July to 30 September 2018.
Lahra MM; Enriquez RP; George CRR;
Commun Dis Intell (2018); 2019 May; 43():. PubMed ID: 31091404
[No Abstract] [Full Text] [Related]
8. Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.
Whiley DM; Trembizki E; Buckley C; Freeman K; Baird RW; Beaman M; Chen M; Donovan B; Kundu RL; Fairley CK; Guy R; Hogan T; Kaldor JM; Karimi M; Limnios A; Regan DG; Ryder N; Su JY; Ward J; Lahra MM
Emerg Infect Dis; 2017 Sep; 23(9):1478-1485. PubMed ID: 28820128
[TBL] [Abstract][Full Text] [Related]
9. Australian Gonococcal Surveillance Programme 1 July to 30 September 2020.
Lahra MM; Shoushtari M; Hogan TR
Commun Dis Intell (2018); 2020 Nov; 44():. PubMed ID: 33349202
[No Abstract] [Full Text] [Related]
10. A pilot study on antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Nepal.
Chaudhary C; Hasan Chaudhary FA; Pandy AR; Karki N; Kansaker P; Das AK; Ross JL; Malla S; Hossain A; Neilsen G; Rahman M
Sex Transm Dis; 2005 Oct; 32(10):641-3. PubMed ID: 16205307
[No Abstract] [Full Text] [Related]
11. Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of N. gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
Zhao L; Liu A; Li R; Zhao S
Int J Antimicrob Agents; 2018 Jan; 51(1):52-56. PubMed ID: 28729124
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009).
Vandepitte J; Hughes P; Matovu G; Bukenya J; Grosskurth H; Lewis DA
Sex Transm Dis; 2014 Apr; 41(4):233-7. PubMed ID: 24622633
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility profile of
Affolabi D; Goma E; Sogbo F; Ahotin G; Orekan J; Massou F; Behanzin L; Guédou F; Alary M
Sex Transm Infect; 2018 Feb; 94(1):20. PubMed ID: 29021407
[No Abstract] [Full Text] [Related]
14. Australian Gonococcal Surveillance Programme Annual Report, 2019.
Lahra MM; Shoushtari M; George CRR; Armstrong BH; Hogan TR;
Commun Dis Intell (2018); 2020 Jul; 44():. PubMed ID: 32664831
[TBL] [Abstract][Full Text] [Related]
15. Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.
Kirkcaldy RD; Zaidi A; Hook EW; Holmes KK; Soge O; del Rio C; Hall G; Papp J; Bolan G; Weinstock HS
Ann Intern Med; 2013 Mar; 158(5 Pt 1):321-8. PubMed ID: 23460055
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant
Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
[TBL] [Abstract][Full Text] [Related]
17. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016.
Yin YP; Han Y; Dai XQ; Zheng HP; Chen SC; Zhu BY; Yong G; Zhong N; Hu LH; Cao WL; Zheng ZJ; Wang F; Zhi Q; Zhu XY; Chen XS
PLoS Med; 2018 Feb; 15(2):e1002499. PubMed ID: 29408881
[TBL] [Abstract][Full Text] [Related]
19. Australian Gonococcal Surveillance Programme, 1 January to 31 March 2018.
Lahra MM; Enriquez RP
Commun Dis Intell (2018); 2019 Jun; 43():. PubMed ID: 31203584
[No Abstract] [Full Text] [Related]
20. Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of
Turner KM; Christensen H; Adams EJ; McAdams D; Fifer H; McDonnell A; Woodford N
BMJ Open; 2017 Jun; 7(6):e015447. PubMed ID: 28615273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
